Studied clinically in Russia for generalized anxiety; not FDA/EMA approved, with limited Western trial data.
Selank is a synthetic peptide based on tuftsin, a naturally occurring immune-signaling fragment, and was also developed in Russia, primarily as an anti-anxiety agent.
Its proposed calming effect is attributed to several actions: modulating GABA signaling (the brain's main 'brake'), slowing the breakdown of the body's own calming peptides (enkephalins), and influencing BDNF — together producing anxiolytic effects without the dependence typical of sedatives.
As with Semax, the supporting evidence comes largely from a Russian clinical tradition and is limited by Western standards; it is not an approved medication.
Searching the published record…
Searching the published record…
Searching the published record…
Studies are surfaced live from the U.S. National Library of Medicine (PubMed). biohackr indexes and links the published record; it does not host or alter source articles.